Article ; Online: Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells.
2024 Volume 14, Issue 1, Page(s) 2824
Abstract: Breast cancer therapy options are limited due to its late diagnosis and poor prognosis. Doxorubicin is the fundamental therapy approach for this disease. Because chemotherapy has numerous adverse effects, the scope of the existing research was to ... ...
Abstract | Breast cancer therapy options are limited due to its late diagnosis and poor prognosis. Doxorubicin is the fundamental therapy approach for this disease. Because chemotherapy has numerous adverse effects, the scope of the existing research was to appraise the synergetic effect of doxorubicin and naringin and explore the underlying mechanism. The cytotoxicity of doxorubicin and naringin on MCF-7 was monitored. Furthermore, the expression of STAT3 and JAK1 as well as the apoptotic and metastatic related genes (Bax, Bcl-2, Survivin, and VEGF) were conducted by immunoblotting assay and qRT-PCR. In addition, a wound healing test was utilized to appraise the migration and metastasis of MCF-7. Our results revealed that naringin and doxorubicin had a synergetic inhibitory influence on MCF-7 cells growth and migration. The synergetic action of doxorubicin and naringin effectively hindered the expression of STAT3, JAK1, Bcl-2, Survivin, and VEGF, with a boost in the level of Bax compared to cells treated with either doxorubicin or naringin. In conclusion, our findings imply that combining doxorubicin with naringin may be a favorable strategy for inhibiting the growth of breast cancer. |
---|---|
MeSH term(s) | Humans ; Female ; Breast Neoplasms/pathology ; Survivin/metabolism ; bcl-2-Associated X Protein ; Vascular Endothelial Growth Factor A/pharmacology ; Apoptosis ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Signal Transduction ; Cell Line, Tumor ; Flavanones |
Chemical Substances | Survivin ; naringin (N7TD9J649B) ; bcl-2-Associated X Protein ; Vascular Endothelial Growth Factor A ; Doxorubicin (80168379AG) ; Proto-Oncogene Proteins c-bcl-2 ; Flavanones |
Language | English |
Publishing date | 2024-02-03 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2615211-3 |
ISSN | 2045-2322 ; 2045-2322 |
ISSN (online) | 2045-2322 |
ISSN | 2045-2322 |
DOI | 10.1038/s41598-024-53320-9 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.